IP Library Granted Patent US 9,777,300
Granted Patent B2
US 9,777,300 · App. 14/273,371 · Granted Oct 3, 2017

Hybrid organic-inorganic system for producing biofuels

Inventors: Yi-Chun Yeh (Emeryville, CA); Steven W. Singer (Berkeley, CA); Swapnil R. Chhabra (Oakland, CA); Harry R. Beller (Berkeley, CA); Jana Mueller (Mountain View, CA)
Assignee: The Regents of the University of California
C12P7/6409C07K1/13C07K14/245C12N1/38C12P5/007C12P5/02C12P5/026C12P7/02C12P7/16C12P7/62C12P7/625Y02E50/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,777,300
App. No.
14/273,371
Granted
Oct 3, 2017
Kind
B2
Abstract

The present invention provides for a system for converting CO 2 and H 2 to one or more biologically derived compounds. In some embodiments, the system comprises a host cell comprising one or more nucleic acids encoding genes for a recombinant surface display protein which is capable of tethering an electrocatalyst molecule, such as a cobalt(II) complex supported by tetradentate polypyridyl ligand 2-bis(2-pyridyl)(methoxy)methyl-6-pyridylpyridine (PY4), and enzymes for synthesizing a biologically derived compound, such as an alkane, alcohol, fatty acid, ester, or isoprenoid.

Claims (15)

1. A host cell comprising: (a) a first membrane-bound protein or peptide bound directly or indirectly to an electrocatalyst molecule, (b) enzymes capable of synthesizing a biologically derived compound, and (c) optionally a second protein or peptide bound to the electrocatalyst molecule, wherein the first protein or peptide is bound to the second protein or peptide; wherein the host cell is Escherichia coli or of the genus Ralstonia , and the electrocatalyst molecule is a cobalt(II) complex supported by tetradentate polypyridyl ligand 2-bis(2-pyridyl)(methoxy)methyl-6-pyridylpyridine (PY4) or a CdSe/ZnS nanoparticle; wherein the biologically derived compound is an alkane, alcohol, fatty acid, ester, or isoprenoid.

2. The host cell of claim 1 , further comprising one or more nucleic acids encoding genes for the first protein or peptide, enzymes for synthesizing a biologically derived compound, and optionally the second protein or peptide.

3. The host cell of claim 1 , wherein the first and/or second protein or peptide is translocated to or outside of the outer membrane of the host cell upon expression within the host cell.

4. The host cell of claim 1 , wherein the electrocatalyst molecule is a cobalt(II) complex supported by a CdSe/ZnS nanoparticle.

5. The host cell of claim 1 , wherein the host cell is of the genus Ralstonia.

6. The host cell of claim 5 , wherein the host cell is R. basilensis, R. campinensis, R. eutropha, R. gilardii, R. insidiosa, R. mannitolilytica, R. metallidurans, R. paucula, R. pickettii, R. respiraculi, R. solanacearum, R. syzygii , or R. taiwanensis.

7. The host cell of claim 6 , wherein the host cell is R. eutropha H16.

8. The host cell of claim 1 , wherein the first protein or peptide is Escherichia coli FhuA and the second protein or peptide is bacteriophage λ pb5.

9. The host cell of claim 1 , wherein the host cell is capable of growing to a cell density of equal to or more than 200 g/L.

10. The host cell of claim 1 , wherein the enzymes capable of synthesizing a biologically derived compound comprise: enzymes of an acyl-ACP reductase/aldehyde decarbonylase pathway, a thioesterase, enzymes of a mevalonate-dependent (MEV) isoprenoid pathway, enzymes of a deoxyxylulose 5-phosphate (DXP) pathway, an amophadiene synthase, a farnesene synthase, a bisabolene synthase, or a squalene synthase.

11. The host cell of claim 10 , wherein the enzymes capable of synthesizing a biologically derived compound comprise a thioesterase, and the biologically derived compound is a fatty acid.

12. The host cell of claim 10 , wherein the enzymes capable of synthesizing a biologically derived compound comprise enzymes of the acyl-ACP reductase/aldehyde decarbonylase pathway, and the biologically derived compound is an alkane.

13. The host cell of claim 10 , wherein the enzymes capable of synthesizing a biologically derived compound comprise enzymes of the mevalonate-dependent (MEV) isoprenoid pathway, and the biologically derived compound is an isoprenoid.

14. The host cell of claim 10 , wherein the enzymes capable of synthesizing a biologically derived compound comprise enzymes of the DXP pathway, and the biologically derived compound is an isoprenoid.

15. The host cell of claim 10 , wherein the enzymes capable of synthesizing a biologically derived compound comprise an amophadiene synthase, farnesene synthase, bisabolene synthase, or squalene synthase, and the biologically derived compound is an amophadiene, farnesene, bisabolene, or squalene, respectively.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 1, 2017
From: YEH, YI-CHUN; SINGER, STEVEN W.; CHHABRA, SWAPNIL R.; BELLER, HARRY R.; MUELLER, JANA
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 043154/0373 →
CONFIRMATORY LICENSE Recorded Jun 6, 2014
From: REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE
To: ENERGY, UNITED STATES DEPARTMENT OF
Reel/Frame 033153/0260 →
Continuity (3)
Continuation PCTUS2012064216 · Nov 8, 2012
Provisional Application 61557357 · Nov 8, 2011
Related Publication 20140242649A1 · Aug 28, 2014